Literature DB >> 4726971

Medulloblastoma: an analysis of time-dose relationships and recurrence patterns.

C E Smith, D M Long, T K Jones, S H Levitt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4726971     DOI： 10.1002/1097-0142(197309)32:3<722::aid-cncr2820320326>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  5 in total

1.  Intra-arterial BCNU in the treatment of recurrent medulloblastoma.

Authors:  K Watne; B Hager; H Hirschberg
Journal:  J Neurooncol       Date:  1990-04       Impact factor: 4.130

2.  Medulloblastoma in childhood. Survival and functional results.

Authors:  J F Hirsch; D Renier; P Czernichow; L Benveniste; A Pierre-Kahn
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

3.  An adoptive immunotherapy of patients with medulloblastoma by lymphokine-activated killer cells (LAK).

Authors:  Y Okamoto; K Shimizu; K Tamura; Y Miyao; M Yamada; Y Matsui; N Tsuda; H Takimoto; T Hayakawa; H Mogami
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

4.  Treatment of medulloblastoma in children: long-term results following surgery, radiotherapy and chemotherapy.

Authors:  C Mazza; A Pasqualin; R Da Pian; E Donati
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

5.  Optimal therapy in medulloblastoma.

Authors:  E B Bongartz; M Bamberg; H E Nau; G Schmitt; C Bayindir
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.